OG Analysis, a global market research firm, has announced the release of their Global Liquid Biopsy Market size, Outlook and Opportunities 2019- 2025: By Circulating Biomarker (Extracellular Vesicles (Evs), Circulating Tumor Cells, Circulating Tumor DNA (CTDNA), Cell-Free DNA and Other Circulating Biomarkers), By Product and Service (Instruments, Assay Kits and Services), By Application (Non-Cancer ... Read more
Liquid biopsy allows the detection of various cancer types through a simple blood draw. It identifies and evaluates fragments of DNA released by tumor cells into the bloodstream. These DNA fragments provide insights about any genetic mutations occurring in the tumor. Liquid biopsy provides a simple and non-invasive alternative to surgical tumor biopsies. It assists physicians in screening, diagnosing, and monitoring cancer without requiring invasive procedures.
